Cargando…
Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review
Although the use of prophylactic granulocyte colony-stimulating factor (G-CSF) in conjunction with myelosuppressive chemotherapy is supported by clinical research evidence and advocated by international clinical guidelines when the consequent risk of febrile neutropenia exceeds 20%, there remains do...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752222/ https://www.ncbi.nlm.nih.gov/pubmed/19756001 http://dx.doi.org/10.1038/sj.bjc.6605271 |